AVTX
Avalo Therapeutics Inc
13.70$
+1.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -28.3% | +489.4% | -12.5% | -9.1% | +53.1% | -8.1% | -8.6% | -1.2% | -6.9% | -14.2% | +391.3% | |
| – | -33.7% | +1,224.8% | -13.8% | -10.2% | +61.2% | -8.6% | -9.3% | -1.2% | -7.5% | -15.6% | +359.3% | |
| – | -27.2% | +1,385.9% | -15.2% | -12.4% | +64.4% | -7.1% | -66.2% | -36.2% | -41.2% | +57.6% | +241.7% | |
| – | -27.2% | +1,385.9% | -15.2% | -12.4% | +64.4% | -7.1% | -9.4% | -1.5% | -11.9% | -16.6% | +388.2% | |
| – | -91.2% | -74.3% | -5.7% | +2,924.2% | -38.8% | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -27.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -6.1% | +1,542.3% | -45.8% | -36.5% | -77.1% | -10.1% | +38.4% | +52.5% | -0.4% | -5.5% | +33.4% | |
| – | -23.1% | +4,570.9% | -55.3% | -37.1% | -88.5% | -19.3% | +64.9% | -13.9% | +62.3% | -10.4% | +82.2% | |
| – | +0.2% | +1.5% | +0.6% | +0.4% | +3.3% | -7.4% | -8.4% | -9.1% | -10.5% | -16.3% | -26.2% | |
| – | -43.5% | +105.4% | -28.6% | +176.9% | -84.4% | +140.6% | +247.4% | -80.0% | -71.1% | +159.9% | +840.2% | |
| – | -50.3% | -1,484.0% | – | – | +531.2% | -7.8% | -14.7% | -12.5% | -9.3% | -17.7% | +556.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +311.5% | +7.2% | +790.6% | +40.9% | -2.9% | +0.4% | +3.0% | +29.3% | +32.2% | +8.6% | +116.9% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.